drugset / Trial / NCT07353671
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate the efficacy and safety of topical Periplaneta americana-derived Meilian Fuxin Solution for the prevention of radiation dermatitis in patients undergoing radiotherapy.
Timeline
- Start
- 2026-03-01
- Primary completion
- 2026-12-31
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meilian Fuxin Solution | Unknown | — | Topical |